Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 1/20 | 0.52 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.51 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.45 |
| ▸ | CDK7 | P50613 | 1/20 | 0.45 |
| ▸ | CDK13 | Q14004 | 1/20 | 0.45 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.45 |
| ▸ | GRM1 | Q13255 | 8/20 | 0.44 |
| ▸ | GRM5 | P41594 | 7/20 | 0.44 |
| ▸ | WDR5 | P61964 | 2/20 | 0.44 |
| ▸ | LIPC | P11150 | 1/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.42 |
| ▸ | QDPR | P09417 | 1/20 | 0.42 |
| ▸ | JAK1 | P23458 | 1/20 | 0.42 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30736692 | 0.92 | NAMPT (0.52) | NAMPTSOS1PDK4CDK7CDK13 | |
| SCHEMBL29071650 | 0.89 | NAMPT (0.51) | NAMPTSOS1PDK4CDK7CDK13 | |
| SCHEMBL3039806 | 0.88 | QDPR (0.46) | NAMPTSOS1QDPR | |
| SCHEMBL24718282 | 0.88 | NAMPT (0.56) | NAMPTSOS1PDK4CDK7CDK13 | |
| SCHEMBL30798377 | 0.88 | NAMPT (0.56) | NAMPTSOS1PDK4CDK7CDK13 | |
| SCHEMBL31612866 | 0.88 | NAMPT (0.53) | NAMPTSOS1PDK4CDK7CDK13 | |
| SCHEMBL15380388 | 0.88 | NAMPT (0.53) | NAMPTSOS1PDK4CDK7CDK13 | |
| SCHEMBL3033965 | 0.86 | NAMPT (0.54) | NAMPTSOS1PDK4CDK7CDK13 | |
| SCHEMBL30736648 | 0.86 | NAMPT (0.54) | NAMPTSOS1PDK4CDK7CDK13 | |
| SCHEMBL19940290 | 0.85 | NAMPT (0.53) | NAMPTSOS1PDK4CDK7CDK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4561575-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |